« Back to Record
Cornely, O. A., Meyer, R. R., Hammond, S. S., Mullane, K. K., Ostermann, H., Ullmann, A., Zimmerli, S., Van Iersel, M. M., Hepler, D. D., Waskin, H., Kartsonis, N., Robertson, M., Maertens, J., Haider, S., Grigg, A., Geddes, M., Aoun, M., Heinz, W. W., Raad, I. I., & Schanz, U. (2017). Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. Journal of antimicrobial chemotherapy, 72(12), 3501. doi:10.1093/jac/dkx263
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/268503



